Period Ending | Dec 31, 2009 | Sep 30, 2009 | Jun 30, 2009 | Mar 31, 2009 |
Total Revenue
|
2,032,379
|
1,801,389
|
1,647,155
|
1,530,460
| Cost of Revenue | 473,399 | 409,700 | 383,045 | 329,414 | |
Gross Profit
|
1,558,980
|
1,391,689
|
1,264,110
|
1,201,046
| |
|
Operating Expenses |
|
Research Development | 239,645 | 269,856 | 241,638 | 188,779 |
|
Selling General and Administrative | 253,897 | 227,427 | 261,411 | 203,951 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,065,438
|
894,406
|
761,061
|
808,316
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 11,299 | 14,017 | 12,923 | 4,158 |
|
Earnings Before Interest And Taxes | 1,076,737 | 908,423 | 773,984 | 812,474 |
|
Interest Expense | 17,290 | 17,217 | 18,484 | 16,671 |
|
Income Before Tax | 1,059,447 | 891,206 | 755,500 | 795,803 |
|
Income Tax Expense | 260,054 | 220,728 | 186,355 | 209,227 |
|
Minority Interest | 2,819 | 7,344 |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 802,212 | 677,822 | 569,145 | 586,576 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
802,212
|
677,822
|
569,145
|
586,576
| Preferred Stock And Other Adjustments |
-
| (4,789) | 2,253 | 2,536 | |
Net Income Applicable To Common Shares
|
$802,212
|
$673,033
|
$571,398
|
$589,112
|
|